An open-label, phase 1 study evaluating safety, tolerability, and pharmacokinetics of linifanib (ABT-869) in Japanese patients with solid tumors.
about
Nonsmall cell lung cancer therapy: insight into multitargeted small-molecule growth factor receptor inhibitorsA phase 1 study of linifanib in combination with carboplatin/paclitaxel as first-line treatment of Japanese patients with advanced or metastatic non-small cell lung cancer (NSCLC).Pharmacodynamic change in plasma angiogenic proteins: a dose-escalation phase 1 study of the multi-kinase inhibitor lenvatinib.Exploring novel KDR inhibitors based on pharmaco-informatics methodology.Anti-vascular endothelial growth factor therapies at the crossroads: linifanib for non-small cell lung cancer.Investigational platelet-derived growth factor receptor kinase inhibitors in breast cancer therapy.Linifanib: current status and future potential in cancer therapy.Phase 1 dose escalation trial of ilorasertib, a dual Aurora/VEGF receptor kinase inhibitor, in patients with hematologic malignancies.Simple, sensitive and rapid determination of linifanib (ABT-869), a novel tyrosine kinase inhibitor in rat plasma by UHPLC-MS/MS.Micelle-enhanced direct spectrofluorimetric method for the determination of linifanib: Application to stability studies.OncomiR-10b hijacks the small molecule inhibitor linifanib in human cancers
P2860
Q27693185-3FD01CBD-F20D-43C0-BF21-FF9734526E4EQ33415143-28E763B5-A4F5-48D1-86CE-BFD98B597BE3Q34468729-7977069B-B9FF-4A3D-97A2-3A665937FD92Q34600778-B3BDB02B-7DCC-4590-9AF7-D892CADE62D7Q36594240-1960A7DA-A289-4C15-9480-927EB886B87AQ38193533-E8F959C2-6B22-43A7-8B7B-A92FFE608646Q38455525-08706491-FA8F-49E2-ADFE-F2DB0F76A3B6Q41463339-C19E2BB7-1A9F-4D55-BF9E-24BE4027FCD0Q41972452-9A2D42C1-975D-4CBB-AC6A-30DA9C6AF3F2Q46742830-D2B2C3ED-42B5-493C-94D1-6E6F55DA0BB7Q59123158-5F21C5FC-2837-465C-A8CA-1D7B32DCD5F0
P2860
An open-label, phase 1 study evaluating safety, tolerability, and pharmacokinetics of linifanib (ABT-869) in Japanese patients with solid tumors.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
An open-label, phase 1 study e ...... se patients with solid tumors.
@ast
An open-label, phase 1 study e ...... se patients with solid tumors.
@en
type
label
An open-label, phase 1 study e ...... se patients with solid tumors.
@ast
An open-label, phase 1 study e ...... se patients with solid tumors.
@en
prefLabel
An open-label, phase 1 study e ...... se patients with solid tumors.
@ast
An open-label, phase 1 study e ...... se patients with solid tumors.
@en
P2093
P2860
P1476
An open-label, phase 1 study e ...... ese patients with solid tumors
@en
P2093
Andrew Coates
Dawn M Carlson
Evelyn M McKeegan
Hiroshi Nokihara
Mark D McKee
Noboru Yamamoto
Peter J Ansell
Rajendra Pradhan
Takashi Shibata
Tomohide Tamura
P2860
P2888
P304
P356
10.1007/S00280-012-1846-6
P577
2012-03-02T00:00:00Z